Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin for ICU patients with COVID-19
IRCT20150221021159N7Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of atorvastatin in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Clinical improvement and Treatment failure. Started Oct 2021; status: completed.
02
Drugs
atorvastatin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20150221021159N7.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20150221021159N7.